{"slideshow_credits": null, "snippet": "While some feminists lend heft to a campaign for a pill to bolster women&#8217;s libido, other groups opted not to join the campaign, concerned that calls of gender bias would undermine what should be an impartial scientific process.", "abstract": "Panel's surprise recommendation to FDA to approve Sprout Pharmaceutical drug flibanserin, first pill to bolster women's libido, raises questions about coalition of prominent feminists who campaigned for drug's approval; campaign divided women's health community, with critics saying it politicized scientific process and potentially played down health risks; those paid to promote drug include Susan Scanlan, whose Even the Score group argued that women's sexuality has been marginalized by medical establishment.", "section_name": "Science", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 1, "organization": ""}, {"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 2, "organization": ""}], "original": "By SABRINA TAVERNISE and ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/06/14/us/aid-to-women-or-bottom-line-advocates-split-on-libido-pill.html", "lead_paragraph": "While some feminists lend heft to a campaign for a pill to bolster women&#8217;s libido, other groups opted not to join the campaign, concerned that calls of gender bias would undermine what should be an impartial scientific process.", "headline": {"main": "Aid to Women, or Bottom Line? Advocates Split on Libido Pill ", "print_headline": "Aid to Women, or Bottom Line? Advocates Split on Libido Pill"}, "_id": "557c94c738f0d85fbd03bfd7", "word_count": "1769", "multimedia": [{"height": 126, "url": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-articleLarge.jpg", "legacy": {"xlarge": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/06/14/us/14libido-JP-SUB/14libido-JP-SUB-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-06-14T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Women and Girls", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Sex", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Sprout Pharmaceuticals Inc", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "7"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "National Women's Health Network", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}